LIPO-4

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameLIPO-4
Drug Alias NameHIV vaccine (INRS)LIPO-4
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionT-cell surface antigen CD4 modulatorsCluster of differentiation 8 modulators
TargetsCluster of differentiation 8T-cell surface antigen CD4
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInrs-Institut Armand Frappier , Université Du Québec
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInrs-Institut Armand Frappier , Université Du Québec
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A